Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.

Chronic Bronchitis Features

Chronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell hyperactivity. Mucus buildup causes wheezing and rhonchi (low, rattling sounds produced as air moves through narrowed, mucus-filled airways). Over time, dyspnea develops, progressing from exertion to rest. Chronic hypoxemia leads to cyanosis (a bluish discoloration of the skin) and stimulates erythropoietin release, causing secondary polycythemia (excess red blood cell production). Pulmonary hypertension may develop and progress to cor pulmonale, presenting with leg swelling, fatigue, and venous congestion.

Emphysema Features

Emphysema is characterized by progressive breathlessness with minimal sputum. Destruction of alveolar walls causes air trapping, reduced elasticity, and lung hyperinflation, resulting in a barrel-shaped chest and a flattened diaphragm. Patients often appear thin, tachypneic, and use accessory muscles and pursed-lip breathing. Gas exchange remains relatively preserved early, so cyanosis appears later.

Combined Clinical Pattern and Management

Most patients exhibit features of both conditions, combining mucus production with airflow limitation and hyperinflation. These overlapping mechanisms reflect COPD’s progressive impact on lung function and systemic health. Early diagnosis, smoking cessation, and treatment are essential to slow progression and improve quality of life.